Matches in Wikidata for { <http://www.wikidata.org/entity/Q88310811> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q88310811 description "2017 թվականի հուլիսի 11-ին հրատարակված գիտական հոդված" @default.
- Q88310811 description "article scientifique publié en 2017" @default.
- Q88310811 description "artículu científicu espublizáu en xunetu de 2017" @default.
- Q88310811 description "scientific article published on 11 July 2017" @default.
- Q88310811 description "wetenschappelijk artikel" @default.
- Q88310811 description "наукова стаття, опублікована в липні 2017" @default.
- Q88310811 name "Healthcare costs among adults with type 2 diabetes initiating saxagliptin or linagliptin: a US-based claims analysis" @default.
- Q88310811 name "Healthcare costs among adults with type 2 diabetes initiating saxagliptin or linagliptin: a US-based claims analysis" @default.
- Q88310811 type Item @default.
- Q88310811 label "Healthcare costs among adults with type 2 diabetes initiating saxagliptin or linagliptin: a US-based claims analysis" @default.
- Q88310811 label "Healthcare costs among adults with type 2 diabetes initiating saxagliptin or linagliptin: a US-based claims analysis" @default.
- Q88310811 prefLabel "Healthcare costs among adults with type 2 diabetes initiating saxagliptin or linagliptin: a US-based claims analysis" @default.
- Q88310811 prefLabel "Healthcare costs among adults with type 2 diabetes initiating saxagliptin or linagliptin: a US-based claims analysis" @default.
- Q88310811 P1433 Q88310811-31DF15E5-D403-494D-8CD3-766FBDE47354 @default.
- Q88310811 P1476 Q88310811-9290A02A-B0C9-4400-8359-35758B9C31E1 @default.
- Q88310811 P2093 Q88310811-5D3B3A08-9E08-42A0-816C-186B3BE4FD90 @default.
- Q88310811 P2093 Q88310811-887F526E-C05D-4FF0-B638-B7A042E55A98 @default.
- Q88310811 P2093 Q88310811-8F3DB2E6-6B68-492A-A5BD-DC0177934121 @default.
- Q88310811 P2093 Q88310811-96BBF97B-70B0-4044-806C-B17B53FE45D5 @default.
- Q88310811 P2093 Q88310811-B381BD12-E2EC-4955-826E-E7DB98A85CEF @default.
- Q88310811 P2093 Q88310811-DDA3C7B3-2718-4D0D-B899-83161BC7F529 @default.
- Q88310811 P2093 Q88310811-EE5E9574-3F7A-4138-89C6-B474FA82216B @default.
- Q88310811 P304 Q88310811-3E09C397-C032-40FB-B82C-B1E4E3BBE83A @default.
- Q88310811 P31 Q88310811-2756232E-8A10-4BB9-B4E0-D7E6E0085CB3 @default.
- Q88310811 P356 Q88310811-88425110-3951-454B-9025-C39B91B7EC16 @default.
- Q88310811 P433 Q88310811-FB67B65A-4173-42CF-9BB2-409BD15416D5 @default.
- Q88310811 P478 Q88310811-5215B864-7BDB-4134-B7EF-65FA49AD27EA @default.
- Q88310811 P577 Q88310811-37955144-DEFB-416E-997A-EF78C41B2776 @default.
- Q88310811 P698 Q88310811-AD18EBA8-AC52-4B90-8FEB-103B606E1BAF @default.
- Q88310811 P921 Q88310811-9D0E3FA9-30A7-4EF5-98CF-7C8418C921C0 @default.
- Q88310811 P921 Q88310811-D612F94B-BFD6-4179-88CF-CC798952A0E7 @default.
- Q88310811 P356 03007995.2017.1343187 @default.
- Q88310811 P698 28613952 @default.
- Q88310811 P1433 Q5195063 @default.
- Q88310811 P1476 "Healthcare costs among adults with type 2 diabetes initiating saxagliptin or linagliptin: a US-based claims analysis" @default.
- Q88310811 P2093 "Amanda M Kong" @default.
- Q88310811 P2093 "Biswarup Mukherjee" @default.
- Q88310811 P2093 "David M Smith" @default.
- Q88310811 P2093 "John J Sheehan" @default.
- Q88310811 P2093 "Matthew A Brouillette" @default.
- Q88310811 P2093 "Sepehr Farahbakhshian" @default.
- Q88310811 P2093 "Trudy Pendergraft" @default.
- Q88310811 P304 "1869-1877" @default.
- Q88310811 P31 Q13442814 @default.
- Q88310811 P356 "10.1080/03007995.2017.1343187" @default.
- Q88310811 P433 "10" @default.
- Q88310811 P478 "33" @default.
- Q88310811 P577 "2017-07-11T00:00:00Z" @default.
- Q88310811 P698 "28613952" @default.
- Q88310811 P921 Q3025883 @default.
- Q88310811 P921 Q909745 @default.